Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147
There is an enormous global public health burden due to antimicrobial-resistant (AMR) Klebsiella pneumoniae high-risk clones. K. pneumoniae ST307 and ST147 are recent additions to the family of successful clones in the species. Both clones likely emerged in Europe during the early to mid-1990s and,...
Saved in:
| Published in | Antimicrobial agents and chemotherapy Vol. 64; no. 10 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
American Society for Microbiology
21.09.2020
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0066-4804 1098-6596 1098-6596 |
| DOI | 10.1128/AAC.01148-20 |
Cover
| Abstract | There is an enormous global public health burden due to antimicrobial-resistant (AMR)
Klebsiella pneumoniae
high-risk clones.
K. pneumoniae
ST307 and ST147 are recent additions to the family of successful clones in the species. Both clones likely emerged in Europe during the early to mid-1990s and, in a relatively short time, became prominent global pathogens, spreading to all continents (with the exception of Antarctica). ST307 and ST147 consist of multiple clades/clusters and are associated with various carbapenemases (i.
There is an enormous global public health burden due to antimicrobial-resistant (AMR)
Klebsiella pneumoniae
high-risk clones.
K. pneumoniae
ST307 and ST147 are recent additions to the family of successful clones in the species. Both clones likely emerged in Europe during the early to mid-1990s and, in a relatively short time, became prominent global pathogens, spreading to all continents (with the exception of Antarctica). ST307 and ST147 consist of multiple clades/clusters and are associated with various carbapenemases (i.e., KPCs, NDMs, OXA-48-like, and VIMs). ST307 is endemic in Italy, Colombia, the United States (Texas), and South Africa, while ST147 is endemic in India, Italy, Greece, and certain North African countries. Both clones have been introduced into regions of nonendemicity, leading to worldwide nosocomial outbreaks. Genomic studies showed ST307 and ST147 contain identical
gyrA
and
parC
mutations and likely obtained plasmids with
bla
CTX-M-15
during the early to mid-2000s, which aided in their global distribution. ST307 and ST147 then acquired plasmids with various carbapenemases during the late 2000s, establishing themselves as important AMR pathogens in certain regions. Both clones are likely underreported due to restricted detection methodologies. ST307 and ST147 have the ability to become major threats to public health due to their worldwide distribution, ability to cause serious infections, and association with AMR, including panresistance. The medical community at large, especially those concerned with antimicrobial resistance, should be aware of the looming threat posed by emerging AMR high-risk clones such as
K. pneumoniae
ST307 and ST147. |
|---|---|
| AbstractList | There is an enormous global public health burden due to antimicrobial-resistant (AMR) Klebsiella pneumoniae high-risk clones. K. pneumoniae ST307 and ST147 are recent additions to the family of successful clones in the species. Both clones likely emerged in Europe during the early to mid-1990s and, in a relatively short time, became prominent global pathogens, spreading to all continents (with the exception of Antarctica). ST307 and ST147 consist of multiple clades/clusters and are associated with various carbapenemases (i.e., KPCs, NDMs, OXA-48-like, and VIMs). ST307 is endemic in Italy, Colombia, the United States (Texas), and South Africa, while ST147 is endemic in India, Italy, Greece, and certain North African countries. Both clones have been introduced into regions of nonendemicity, leading to worldwide nosocomial outbreaks. Genomic studies showed ST307 and ST147 contain identical gyrA and parC mutations and likely obtained plasmids with blaCTX-M-15 during the early to mid-2000s, which aided in their global distribution. ST307 and ST147 then acquired plasmids with various carbapenemases during the late 2000s, establishing themselves as important AMR pathogens in certain regions. Both clones are likely underreported due to restricted detection methodologies. ST307 and ST147 have the ability to become major threats to public health due to their worldwide distribution, ability to cause serious infections, and association with AMR, including panresistance. The medical community at large, especially those concerned with antimicrobial resistance, should be aware of the looming threat posed by emerging AMR high-risk clones such as K. pneumoniae ST307 and ST147. There is an enormous global public health burden due to antimicrobial-resistant (AMR) Klebsiella pneumoniae high-risk clones. K. pneumoniae ST307 and ST147 are recent additions to the family of successful clones in the species. Both clones likely emerged in Europe during the early to mid-1990s and, in a relatively short time, became prominent global pathogens, spreading to all continents (with the exception of Antarctica). ST307 and ST147 consist of multiple clades/clusters and are associated with various carbapenemases (i. There is an enormous global public health burden due to antimicrobial-resistant (AMR) Klebsiella pneumoniae high-risk clones. K. pneumoniae ST307 and ST147 are recent additions to the family of successful clones in the species. Both clones likely emerged in Europe during the early to mid-1990s and, in a relatively short time, became prominent global pathogens, spreading to all continents (with the exception of Antarctica). ST307 and ST147 consist of multiple clades/clusters and are associated with various carbapenemases (i.e., KPCs, NDMs, OXA-48-like, and VIMs). ST307 is endemic in Italy, Colombia, the United States (Texas), and South Africa, while ST147 is endemic in India, Italy, Greece, and certain North African countries. Both clones have been introduced into regions of nonendemicity, leading to worldwide nosocomial outbreaks. Genomic studies showed ST307 and ST147 contain identical gyrA and parC mutations and likely obtained plasmids with bla CTX-M-15 during the early to mid-2000s, which aided in their global distribution. ST307 and ST147 then acquired plasmids with various carbapenemases during the late 2000s, establishing themselves as important AMR pathogens in certain regions. Both clones are likely underreported due to restricted detection methodologies. ST307 and ST147 have the ability to become major threats to public health due to their worldwide distribution, ability to cause serious infections, and association with AMR, including panresistance. The medical community at large, especially those concerned with antimicrobial resistance, should be aware of the looming threat posed by emerging AMR high-risk clones such as K. pneumoniae ST307 and ST147. There is an enormous global public health burden due to antimicrobial-resistant (AMR) Klebsiella pneumoniae high-risk clones. K. pneumoniae ST307 and ST147 are recent additions to the family of successful clones in the species. Both clones likely emerged in Europe during the early to mid-1990s and, in a relatively short time, became prominent global pathogens, spreading to all continents (with the exception of Antarctica). ST307 and ST147 consist of multiple clades/clusters and are associated with various carbapenemases (i.e., KPCs, NDMs, OXA-48-like, and VIMs). ST307 is endemic in Italy, Colombia, the United States (Texas), and South Africa, while ST147 is endemic in India, Italy, Greece, and certain North African countries. Both clones have been introduced into regions of nonendemicity, leading to worldwide nosocomial outbreaks. Genomic studies showed ST307 and ST147 contain identical gyrA and parC mutations and likely obtained plasmids with blaCTX-M-15 during the early to mid-2000s, which aided in their global distribution. ST307 and ST147 then acquired plasmids with various carbapenemases during the late 2000s, establishing themselves as important AMR pathogens in certain regions. Both clones are likely underreported due to restricted detection methodologies. ST307 and ST147 have the ability to become major threats to public health due to their worldwide distribution, ability to cause serious infections, and association with AMR, including panresistance. The medical community at large, especially those concerned with antimicrobial resistance, should be aware of the looming threat posed by emerging AMR high-risk clones such as K. pneumoniae ST307 and ST147.There is an enormous global public health burden due to antimicrobial-resistant (AMR) Klebsiella pneumoniae high-risk clones. K. pneumoniae ST307 and ST147 are recent additions to the family of successful clones in the species. Both clones likely emerged in Europe during the early to mid-1990s and, in a relatively short time, became prominent global pathogens, spreading to all continents (with the exception of Antarctica). ST307 and ST147 consist of multiple clades/clusters and are associated with various carbapenemases (i.e., KPCs, NDMs, OXA-48-like, and VIMs). ST307 is endemic in Italy, Colombia, the United States (Texas), and South Africa, while ST147 is endemic in India, Italy, Greece, and certain North African countries. Both clones have been introduced into regions of nonendemicity, leading to worldwide nosocomial outbreaks. Genomic studies showed ST307 and ST147 contain identical gyrA and parC mutations and likely obtained plasmids with blaCTX-M-15 during the early to mid-2000s, which aided in their global distribution. ST307 and ST147 then acquired plasmids with various carbapenemases during the late 2000s, establishing themselves as important AMR pathogens in certain regions. Both clones are likely underreported due to restricted detection methodologies. ST307 and ST147 have the ability to become major threats to public health due to their worldwide distribution, ability to cause serious infections, and association with AMR, including panresistance. The medical community at large, especially those concerned with antimicrobial resistance, should be aware of the looming threat posed by emerging AMR high-risk clones such as K. pneumoniae ST307 and ST147. There is an enormous global public health burden due to antimicrobial-resistant (AMR) high-risk clones. ST307 and ST147 are recent additions to the family of successful clones in the species. Both clones likely emerged in Europe during the early to mid-1990s and, in a relatively short time, became prominent global pathogens, spreading to all continents (with the exception of Antarctica). ST307 and ST147 consist of multiple clades/clusters and are associated with various carbapenemases (i.e., KPCs, NDMs, OXA-48-like, and VIMs). ST307 is endemic in Italy, Colombia, the United States (Texas), and South Africa, while ST147 is endemic in India, Italy, Greece, and certain North African countries. Both clones have been introduced into regions of nonendemicity, leading to worldwide nosocomial outbreaks. Genomic studies showed ST307 and ST147 contain identical and mutations and likely obtained plasmids with during the early to mid-2000s, which aided in their global distribution. ST307 and ST147 then acquired plasmids with various carbapenemases during the late 2000s, establishing themselves as important AMR pathogens in certain regions. Both clones are likely underreported due to restricted detection methodologies. ST307 and ST147 have the ability to become major threats to public health due to their worldwide distribution, ability to cause serious infections, and association with AMR, including panresistance. The medical community at large, especially those concerned with antimicrobial resistance, should be aware of the looming threat posed by emerging AMR high-risk clones such as ST307 and ST147. |
| Author | Kreiswirth, Barry N. Peirano, Gisele Chen, Liang Pitout, Johann D. D. |
| Author_xml | – sequence: 1 givenname: Gisele surname: Peirano fullname: Peirano, Gisele organization: Alberta Precision Laboratories, Calgary, Alberta, Canada, University of Calgary, Calgary, Alberta, Canada – sequence: 2 givenname: Liang orcidid: 0000-0001-5845-2235 surname: Chen fullname: Chen, Liang organization: Hackensack Meridian Health Center for Discovery and Innovation, Nutley, New Jersey, USA, Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey, USA – sequence: 3 givenname: Barry N. surname: Kreiswirth fullname: Kreiswirth, Barry N. organization: Hackensack Meridian Health Center for Discovery and Innovation, Nutley, New Jersey, USA, Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey, USA – sequence: 4 givenname: Johann D. D. orcidid: 0000-0002-4547-4707 surname: Pitout fullname: Pitout, Johann D. D. organization: Alberta Precision Laboratories, Calgary, Alberta, Canada, University of Calgary, Calgary, Alberta, Canada, University of Pretoria, Pretoria, Gauteng, South Africa |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32747358$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kUFv1DAQhS1URLcLN84oR5BImbHj2LkgrVYtRVRCKkUcLTs72bok9hInSPz7etkWAYKLx5bffHoz74QdhRiIsecIp4hcv1mt1qeAWOmSwyO2QGh0WcumPmILgLouKw3VMTtJ6RbyWzbwhB0LriolpF6wL2cDjVsftsUqTH7w7Ridt315RcmnyYapuPDbm_LKp6_Fh55c8tT3ttgFmocYvKVi3Wc_qfh0LUAVNmzyDSv1lD3ubJ_o2X1dss_nZ9fri_Ly47v369VlaSvUU0mOJHIQzUZUwDfQgXBd4zp0tVAou8YiONsQOLAKtZQtdlrXllArqbAVS_b2wN3NbqBNS2EabW92ox_s-MNE682fP8HfmG38bpQELRuRAS_vAWP8NlOazOBTux8yUJyT4ZUAoUDlc8leHaQ2DdzcxnkMeTSDYPZBmByE-RmE4Xvti999_TL0sPks4AdB3nhKI3Wm9ZOdfNzb9P3_qK__anrg_lN-B8CaonA |
| CitedBy_id | crossref_primary_10_3390_ijms26020504 crossref_primary_10_1128_aac_00030_23 crossref_primary_10_1016_j_ijmm_2025_151645 crossref_primary_10_1099_mgen_0_000737 crossref_primary_10_1128_jcm_01515_24 crossref_primary_10_1128_aac_00368_23 crossref_primary_10_1128_aac_00511_22 crossref_primary_10_1016_j_jhazmat_2024_134660 crossref_primary_10_1128_msystems_01297_21 crossref_primary_10_1016_j_jgar_2021_07_006 crossref_primary_10_1016_j_ijantimicag_2022_106594 crossref_primary_10_1016_j_jcis_2022_09_100 crossref_primary_10_3390_antibiotics11101286 crossref_primary_10_1016_j_jiph_2024_04_010 crossref_primary_10_1038_s41579_024_01054_w crossref_primary_10_1128_spectrum_01910_24 crossref_primary_10_1093_jambio_lxad130 crossref_primary_10_1093_jac_dkab495 crossref_primary_10_1093_jac_dkae123 crossref_primary_10_1128_spectrum_03017_23 crossref_primary_10_1186_s13073_025_01428_6 crossref_primary_10_1007_s10096_024_05016_1 crossref_primary_10_3390_microorganisms10071426 crossref_primary_10_1016_j_phrs_2024_107254 crossref_primary_10_1186_s12866_024_03389_z crossref_primary_10_3390_antibiotics11091160 crossref_primary_10_1016_j_genrep_2024_102101 crossref_primary_10_1089_mdr_2024_0065 crossref_primary_10_1099_mgen_0_001032 crossref_primary_10_1038_s44321_023_00007_9 crossref_primary_10_3389_fmicb_2024_1334268 crossref_primary_10_1128_jcm_00259_23 crossref_primary_10_1186_s13756_024_01370_z crossref_primary_10_3389_fphar_2021_716324 crossref_primary_10_1186_s13073_023_01159_6 crossref_primary_10_2166_wh_2023_237 crossref_primary_10_1016_j_jgar_2023_10_008 crossref_primary_10_3390_pathogens12050743 crossref_primary_10_1016_j_jgar_2024_06_020 crossref_primary_10_1016_j_scitotenv_2023_167160 crossref_primary_10_1016_S2666_5247_21_00268_8 crossref_primary_10_3201_eid2805_212535 crossref_primary_10_3390_antibiotics13020194 crossref_primary_10_1016_j_jhin_2024_04_014 crossref_primary_10_1371_journal_pone_0296709 crossref_primary_10_3390_antibiotics11091171 crossref_primary_10_1016_j_ijantimicag_2021_106456 crossref_primary_10_1016_j_jgar_2025_01_001 crossref_primary_10_3390_antibiotics10101174 crossref_primary_10_1093_jac_dkac329 crossref_primary_10_3390_antibiotics10080979 crossref_primary_10_1128_msystems_01369_23 crossref_primary_10_7554_eLife_67310 crossref_primary_10_1016_j_ijbiomac_2025_140887 crossref_primary_10_1099_acmi_0_000509_v4 crossref_primary_10_1093_jac_dkac045 crossref_primary_10_1093_jambio_lxaf017 crossref_primary_10_1128_CMR_00006_21 crossref_primary_10_3390_antibiotics11111616 crossref_primary_10_1371_journal_pmed_1004233 crossref_primary_10_3390_antibiotics12030535 crossref_primary_10_1089_mdr_2021_0128 crossref_primary_10_1093_jacamr_dlac097 crossref_primary_10_2807_1560_7917_ES_2023_28_42_2300522 crossref_primary_10_3390_ijms25042134 crossref_primary_10_1038_s41598_024_70910_9 crossref_primary_10_1128_aac_01462_24 crossref_primary_10_48022_mbl_2410_10001 crossref_primary_10_2807_1560_7917_ES_2023_28_47_2300571 crossref_primary_10_3390_antibiotics13010014 crossref_primary_10_1099_acmi_0_000667_v4 crossref_primary_10_1016_j_jgar_2025_01_009 crossref_primary_10_1128_iai_00482_23 crossref_primary_10_1016_j_ijfoodmicro_2024_110605 crossref_primary_10_1016_j_jhin_2023_09_015 crossref_primary_10_1128_spectrum_04011_22 crossref_primary_10_1093_jac_dkad086 crossref_primary_10_3390_pathogens13010011 crossref_primary_10_1111_1462_2920_15689 crossref_primary_10_1016_j_scitotenv_2021_151339 crossref_primary_10_1007_s10096_022_04514_4 crossref_primary_10_3390_antibiotics13020170 crossref_primary_10_2147_IDR_S455979 crossref_primary_10_1093_infdis_jiae616 crossref_primary_10_1016_j_ijheh_2022_114075 crossref_primary_10_2807_1560_7917_ES_2023_28_42_2300095 crossref_primary_10_3390_antibiotics14010063 crossref_primary_10_3390_antibiotics14010062 crossref_primary_10_1186_s12866_024_03720_8 crossref_primary_10_3390_biomed4030022 crossref_primary_10_1186_s12941_023_00601_2 crossref_primary_10_1016_j_jgar_2022_01_016 crossref_primary_10_3201_eid2710_211265 crossref_primary_10_3389_fmicb_2024_1502593 crossref_primary_10_1128_aac_01339_23 crossref_primary_10_1007_s10096_024_04947_z crossref_primary_10_1186_s12879_024_10368_2 crossref_primary_10_1016_j_drup_2024_101124 crossref_primary_10_2147_IDR_S403448 crossref_primary_10_2217_fmb_2020_0246 crossref_primary_10_1038_s41586_025_08608_9 crossref_primary_10_3390_antibiotics12091430 crossref_primary_10_1089_mdr_2023_0134 crossref_primary_10_2147_IDR_S478580 crossref_primary_10_1080_14787210_2023_2184348 crossref_primary_10_1186_s12889_024_20474_0 crossref_primary_10_1007_s10096_024_05010_7 crossref_primary_10_1111_lam_13818 crossref_primary_10_3389_fpubh_2024_1357345 crossref_primary_10_1007_s40121_024_01097_9 crossref_primary_10_1038_s41467_024_49851_4 crossref_primary_10_3390_antibiotics10010089 crossref_primary_10_1186_s12929_023_00960_0 crossref_primary_10_1016_j_cmi_2021_06_031 crossref_primary_10_1016_j_jgar_2024_01_015 crossref_primary_10_1080_22221751_2024_2427793 crossref_primary_10_1016_j_ijantimicag_2021_106389 crossref_primary_10_1186_s12866_024_03306_4 crossref_primary_10_48022_mbl_2310_10005 crossref_primary_10_3389_fmicb_2024_1365011 crossref_primary_10_1093_jac_dkab207 crossref_primary_10_1016_j_jgar_2022_08_014 crossref_primary_10_1186_s12866_024_03465_4 crossref_primary_10_1128_cmr_00054_22 crossref_primary_10_1186_s13756_024_01429_x crossref_primary_10_2807_1560_7917_ES_2021_26_21_2000022 crossref_primary_10_1038_s41467_024_49349_z crossref_primary_10_3390_antibiotics11010066 crossref_primary_10_1093_femsec_fiac045 crossref_primary_10_3389_fmicb_2020_581711 crossref_primary_10_1128_spectrum_01242_22 crossref_primary_10_1016_j_jmii_2024_03_004 crossref_primary_10_1128_AAC_02660_20 crossref_primary_10_3390_pathogens12030479 crossref_primary_10_1093_cid_ciab784 crossref_primary_10_1073_pnas_2110227118 crossref_primary_10_3390_antibiotics11010007 crossref_primary_10_3389_fmicb_2022_897161 crossref_primary_10_1093_jacamr_dlab092 crossref_primary_10_3390_microorganisms9091985 crossref_primary_10_1016_j_meegid_2024_105583 crossref_primary_10_1093_ofid_ofad176 crossref_primary_10_2807_1560_7917_ES_2024_29_47_2400587 crossref_primary_10_3390_antibiotics14010042 crossref_primary_10_1007_s42770_024_01299_w crossref_primary_10_3390_applmicrobiol4020054 crossref_primary_10_3390_antibiotics13030281 crossref_primary_10_3390_genes14051037 crossref_primary_10_1038_s41467_024_51374_x crossref_primary_10_1038_s41598_024_55705_2 crossref_primary_10_1016_j_ijheh_2022_113968 crossref_primary_10_1093_cid_ciab777 crossref_primary_10_1093_jacamr_dlae124 crossref_primary_10_3390_antibiotics12091377 crossref_primary_10_1016_j_jgar_2024_11_010 crossref_primary_10_1007_s40121_023_00791_4 crossref_primary_10_3390_microorganisms11020525 crossref_primary_10_1093_nar_gkae516 crossref_primary_10_1007_s10482_024_01955_z crossref_primary_10_3390_pathogens10111426 crossref_primary_10_1080_14787210_2024_2305854 crossref_primary_10_1099_mgen_0_001016 crossref_primary_10_1186_s12941_022_00551_1 crossref_primary_10_3390_microorganisms9040762 crossref_primary_10_1186_s13568_024_01737_w crossref_primary_10_1016_j_ijantimicag_2024_107388 crossref_primary_10_1371_journal_pone_0303353 crossref_primary_10_3390_microorganisms10020416 crossref_primary_10_1016_j_jgar_2023_12_022 crossref_primary_10_1186_s13756_023_01236_w crossref_primary_10_3390_antibiotics12010107 crossref_primary_10_3390_microorganisms10071364 crossref_primary_10_3389_fmicb_2022_838392 crossref_primary_10_1128_AAC_01160_21 crossref_primary_10_1128_spectrum_02287_21 crossref_primary_10_1007_s10096_023_04552_6 crossref_primary_10_1128_jcm_02245_21 crossref_primary_10_3390_antibiotics9100675 crossref_primary_10_1016_j_envres_2023_116928 crossref_primary_10_1186_s12941_021_00467_2 crossref_primary_10_1186_s12941_024_00769_1 crossref_primary_10_1128_mbio_00497_22 crossref_primary_10_3390_pathogens13110945 |
| Cites_doi | 10.3389/fmicb.2016.01000 10.1093/jac/dkw277 10.1371/journal.pone.0179651 10.1089/mdr.2012.0219 10.1093/jac/dks026 10.1016/j.diagmicrobio.2018.02.018 10.1128/JCM.01404-14 10.1093/jac/dks299 10.1093/jac/dkr166 10.1016/j.ijantimicag.2018.04.004 10.1016/j.diagmicrobio.2015.07.023 10.1089/mdr.2017.0165 10.1016/j.diagmicrobio.2011.06.013 10.1099/jmm.0.000653 10.1128/AAC.00841-17 10.1128/AEM.00258-15 10.1089/mdr.2013.0021 10.3201/eid2508.171730 10.1007/s11356-016-6079-5 10.1093/jac/dkz550 10.1128/CMR.00116-14 10.1093/jac/dkv467 10.1016/j.diagmicrobio.2013.08.001 10.1007/s10096-013-2022-6 10.1093/jac/dkz193 10.1016/j.jgar.2019.06.005 10.1093/jac/dkn287 10.1128/AAC.06142-11 10.3201/eid2504.181482 10.1128/AAC.02457-17 10.1093/jac/dkx216 10.1093/cid/cix270 10.12688/f1000research.10609.1 10.1128/JCM.00162-14 10.1016/j.ijid.2014.04.026 10.1089/mdr.2012.0238 10.1093/jac/dky492 10.1128/AAC.02550-16 10.1186/s12879-020-4889-z 10.2807/1560-7917.ES.2017.22.49.17-00048 10.1016/j.meegid.2020.104265 10.1089/mdr.2013.0100 10.1089/mdr.2018.0327 10.1128/CMR.00135-18 10.1128/CMR.00102-19 10.1016/j.ijantimicag.2013.02.017 10.3389/fmicb.2016.01859 10.3389/fvets.2018.00062 10.1128/AAC.01686-12 10.2807/1560-7917.es2015.20.23.21150 10.1099/mgen.0.000110 10.1128/AEM.01906-19 10.1016/j.jhin.2018.10.022 10.1126/science.aar3777 10.1093/jac/dkv355 10.1128/AAC.02101-17 10.1128/AAC.00238-11 10.1038/s41579-019-0315-1 10.1016/j.diagmicrobio.2013.11.024 10.1128/AAC.01019-15 10.1016/j.ijantimicag.2020.105903 10.3389/fmicb.2018.00150 10.1016/j.jgar.2017.10.023 10.1111/j.1469-0691.2011.03532.x 10.1089/mdr.2015.0001 10.1017/ice.2019.304 10.1111/1469-0691.12577 10.3390/ani10020332 10.1128/AAC.02610-16 10.1128/AAC.02640-16 10.2807/1560-7917.ES.2020.25.6.2000085 10.3389/fmicb.2020.00271 10.1371/journal.pone.0160754 10.1186/1757-4749-4-7 10.1128/AAC.00454-17 10.1093/jac/dkp264 10.1099/mgen.0.000349 10.1099/jmm.0.073767-0 10.3389/fmicb.2016.01021 10.1128/AAC.01775-15 10.1016/j.ijmm.2014.08.003 10.1128/AAC.00418-17 10.1371/journal.pone.0132936 10.1128/mBio.00489-17 10.1111/1469-0691.12727 10.2807/1560-7917.ES.2019.24.50.1900734 10.1007/s40265-019-01180-3 |
| ContentType | Journal Article |
| Copyright | Copyright © 2020 American Society for Microbiology. Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology |
| Copyright_xml | – notice: Copyright © 2020 American Society for Microbiology. – notice: Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology |
| DBID | AAYXX CITATION NPM 7X8 5PM |
| DOI | 10.1128/AAC.01148-20 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology Pharmacy, Therapeutics, & Pharmacology |
| DocumentTitleAlternate | Minireview |
| EISSN | 1098-6596 |
| ExternalDocumentID | PMC7508593 01148-20 32747358 10_1128_AAC_01148_20 |
| Genre | Journal Article Review Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R01 AI090155 – fundername: NIAID NIH HHS grantid: R21 AI117338 – fundername: HHS | National Institutes of Health (NIH) grantid: R01AI090155 funderid: https://doi.org/10.13039/100000002 – fundername: HHS | National Institutes of Health (NIH) grantid: R21AI117338 funderid: https://doi.org/10.13039/100000002 – fundername: Canadian Institutes of Health Research (CIHR) grantid: 10016015 funderid: https://doi.org/10.13039/501100000024 – fundername: ; grantid: R01AI090155 – fundername: ; grantid: R21AI117338 – fundername: ; grantid: 10016015 |
| GroupedDBID | --- .55 0R~ 23M 2WC 39C 4.4 53G 5GY 5RE 5VS 6J9 AAGFI AAYXX ACGFO ADBBV AENEX AGVNZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW CITATION CS3 DIK E3Z EBS F5P FRP GX1 H13 HH5 HYE HZ~ H~9 K-O KQ8 L7B LSO O9- OK1 P2P RHI RNS RPM RSF TR2 UHB W2D W8F WH7 WOQ X7M NPM RHF - 0R 55 AAPBV ABFLS ADACO BXI HZ ZA5 7X8 5PM |
| ID | FETCH-LOGICAL-a418t-ebe512039d3402d0f03bf9bf1b63715f9a10ba9e0b0a71855c1f886ae187571c3 |
| ISSN | 0066-4804 1098-6596 |
| IngestDate | Thu Aug 21 18:17:58 EDT 2025 Thu Sep 04 17:11:48 EDT 2025 Tue Dec 28 13:59:22 EST 2021 Thu Jan 02 22:56:42 EST 2025 Thu Apr 24 23:08:46 EDT 2025 Tue Jul 01 04:13:16 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Keywords | antimicrobial resistance high-risk clones |
| Language | English |
| License | Copyright © 2020 American Society for Microbiology. All Rights Reserved. https://doi.org/10.1128/ASMCopyrightv2 All Rights Reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-a418t-ebe512039d3402d0f03bf9bf1b63715f9a10ba9e0b0a71855c1f886ae187571c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Citation Peirano G, Chen L, Kreiswirth BN, Pitout JDD. 2020. Emerging antimicrobial-resistant high-risk Klebsiella pneumoniae clones ST307 and ST147. Antimicrob Agents Chemother 64:e01148-20. https://doi.org/10.1128/AAC.01148-20. |
| ORCID | 0000-0002-4547-4707 0000-0001-5845-2235 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/7508593 |
| PMID | 32747358 |
| PQID | 2430370730 |
| PQPubID | 23479 |
| PageCount | 14 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7508593 proquest_miscellaneous_2430370730 asm2_journals_10_1128_AAC_01148_20 pubmed_primary_32747358 crossref_citationtrail_10_1128_AAC_01148_20 crossref_primary_10_1128_AAC_01148_20 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20200921 |
| PublicationDateYYYYMMDD | 2020-09-21 |
| PublicationDate_xml | – month: 9 year: 2020 text: 20200921 day: 21 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
| PublicationTitle | Antimicrobial agents and chemotherapy |
| PublicationTitleAbbrev | Antimicrob Agents Chemother |
| PublicationTitleAlternate | Antimicrob Agents Chemother |
| PublicationYear | 2020 |
| Publisher | American Society for Microbiology |
| Publisher_xml | – name: American Society for Microbiology |
| References | e_1_3_2_26_2 e_1_3_2_49_2 e_1_3_2_28_2 e_1_3_2_41_2 e_1_3_2_64_2 e_1_3_2_87_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_62_2 e_1_3_2_85_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_68_2 e_1_3_2_24_2 e_1_3_2_47_2 e_1_3_2_66_2 e_1_3_2_89_2 e_1_3_2_60_2 e_1_3_2_83_2 e_1_3_2_81_2 e_1_3_2_9_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_39_2 e_1_3_2_54_2 e_1_3_2_75_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_52_2 e_1_3_2_73_2 e_1_3_2_5_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_58_2 e_1_3_2_79_2 e_1_3_2_3_2 e_1_3_2_14_2 e_1_3_2_35_2 e_1_3_2_56_2 e_1_3_2_77_2 e_1_3_2_50_2 e_1_3_2_71_2 e_1_3_2_90_2 e_1_3_2_27_2 e_1_3_2_48_2 e_1_3_2_29_2 e_1_3_2_40_2 e_1_3_2_65_2 e_1_3_2_86_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_63_2 e_1_3_2_84_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_69_2 e_1_3_2_25_2 e_1_3_2_46_2 e_1_3_2_67_2 e_1_3_2_88_2 e_1_3_2_61_2 e_1_3_2_82_2 e_1_3_2_80_2 Lazareva IV (e_1_3_2_18_2) 2016; 61 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_17_2 e_1_3_2_59_2 e_1_3_2_6_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_53_2 e_1_3_2_76_2 e_1_3_2_32_2 e_1_3_2_51_2 e_1_3_2_74_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_57_2 e_1_3_2_4_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_55_2 e_1_3_2_78_2 e_1_3_2_2_2 e_1_3_2_91_2 e_1_3_2_72_2 e_1_3_2_70_2 Lowe, M, Kock, MM, Coetzee, J, Hoosien, E, Peirano, G, Strydom, KA, Ehlers, MM, Mbelle, NM, Shashkina, E, Haslam, DB, Dhawan, P, Donnelly, RJ, Chen, L, Kreiswirth, BN, Pitout, JDD (B22) 2019; 25 Protonotariou, E, Poulou, A, Politi, L, Sgouropoulos, I, Metallidis, S, Kachrimanidou, M, Pournaras, S, Tsakris, A, Skoura, L (B67) 2018; 52 Habeeb, MA, Haque, A, Nematzadeh, S, Iversen, A, Giske, CG (B10) 2013; 41 Mansour, W, Grami, R, Ben Haj Khalifa, A, Dahmen, S, Chatre, P, Haenni, M, Aouni, M, Madec, JY (B15) 2015; 83 Piazza, A, Comandatore, F, Romeri, F, Brilli, M, Dichirico, B, Ridolfo, A, Antona, C, Bandi, C, Gismondo, MR, Rimoldi, SG (B36) 2019; 25 Cejas, D, Elena, A, Guevara Nuñez, D, Sevillano Platero, P, De Paulis, A, Magariños, F, Alfonso, C, Berger, MA, Fernández-Canigia, L, Gutkind, G, Radice, M (B33) 2019; 18 Gharout-Sait, A, Alsharapy, SA, Brasme, L, Touati, A, Kermas, R, Bakour, S, Guillard, T, de Champs, C (B54) 2014; 63 Rojas, LJ, Hujer, AM, Rudin, SD, Wright, MS, Domitrovic, TN, Marshall, SH, Hujer, KM, Richter, SS, Cober, E, Perez, F, Adams, MD, van Duin, D, Bonomo, RA (B63) 2017; 61 Bonura, C, Giuffre, M, Aleo, A, Fasciana, T, Di Bernardo, F, Stampone, T, Giammanco, A, Palma, DM, Mammina, C (B11) 2015; 10 Lee, C-S, Vasoo, S, Hu, F, Patel, R, Doi, Y (B55) 2014; 52 Peirano, G, Bradford, PA, Kazmierczak, KM, Chen, L, Kreiswirth, BN, Pitout, JD (B62) 2017; 61 Wyres, KL, Lam, MMC, Holt, KE (B5) 2020; 18 Liapis, E, Pantel, A, Robert, J, Nicolas-Chanoine, M-H, Cavalié, L, van der Mee-Marquet, N, de Champs, C, Aissa, N, Eloy, C, Blanc, V, Guyeux, C, Hocquet, D, Lavigne, J-P, Bertrand, X (B56) 2014; 20 Pirš, M, Cerar Kišek, T, Križan Hergouth, V, Seme, K, Mueller Premru, M, Jeverica, S, Logar, M, Mrvič, T, Žnidaršič, B, Jordan Markočič, O, Lejko Zupanc, T (B83) 2019; 101 Hamzaoui, Z, Ocampo-Sosa, A, Maamar, E, Fernandez Martinez, M, Ferjani, S, Hammami, S, Harbaoui, S, Genel, N, Arlet, G, Saidani, M, Slim, A, Boutiba-Ben Boubaker, I, Martinez-Martinez, L (B65) 2018; 24 Pitout, JDD, Finn, TJ (B1) 2020; 81 Perdigao, J, Modesto, A, Pereira, AL, Neto, O, Matos, V, Godinho, A, Phelan, J, Charleston, J, Spadar, A, de Sessions, PF, Hibberd, M, Campino, S, Costa, A, Fernandes, F, Ferreira, F, Correia, AB, Goncalves, L, Clark, TG, Duarte, A (B25) 2020 Villa, L, Feudi, C, Fortini, D, Brisse, S, Passet, V, Bonura, C, Endimiani, A, Mammina, C, Ocampo, AM, Jimenez, JN, Doumith, M, Woodford, N, Hopkins, K, Carattoli, A (B20) 2017; 3 Schaufler, K, Nowak, K, Dux, A, Semmler, T, Villa, L, Kourouma, L, Bangoura, K, Wieler, LH, Leendertz, FH, Guenther, S (B30) 2018; 9 Strydom, KA, Chen, L, Kock, MM, Stoltz, AC, Peirano, G, Nobrega, DB, Lowe, M, Ehlers, MM, Mbelle, NM, Kreiswirth, BN, Pitout, JDD (B26) 2020; 75 Damjanova, I, Tóth, A, Pászti, J, Hajbel-Vékony, G, Jakab, M, Berta, J, Milch, H, Füzi, M (B40) 2008; 62 Toth, A, Kocsis, B, Damjanova, I, Kristof, K, Janvari, L, Paszti, J, Csercsik, R, Topf, J, Szabo, D, Hamar, P, Nagy, K, Fuzi, M (B86) 2014; 33 Ovejero, CM, Escudero, JA, Thomas-Lopez, D, Hoefer, A, Moyano, G, Montero, N, Martin-Espada, C, Gonzalez-Zorn, B (B72) 2017; 61 Muggeo, A, Guillard, T, Klein, F, Reffuveille, F, Francois, C, Babosan, A, Bajolet, O, Bertrand, X, de Champs, C (B87) 2018; 13 Giske, CG, Froding, I, Hasan, CM, Turlej-Rogacka, A, Toleman, M, Livermore, D, Woodford, N, Walsh, TR (B48) 2012; 56 Pitout, JDD, Peirano, G, Kock, MM, Strydom, KA, Matsumura, Y (B7) 2019; 33 Fuzi, M, Rodriguez Bano, J, Toth, A (B89) 2020; 11 Maamar, E, Ferjani, S, Jendoubi, A, Hammami, S, Hamzaoui, Z, Mayonnove-Coulange, L, Saidani, M, Kammoun, A, Rehaiem, A, Ghedira, S, Houissa, M, Boutiba-Ben Boubaker, I, Slim, A, Dubois, V (B71) 2016; 7 Peirano, G, Lascols, C, Hackel, M, Hoban, DJ, Pitout, JD (B78) 2014; 78 Boonstra, MB, Spijkerman, DCM, Voor In 't Holt, AF, van der Laan, RJ, Bode, LGM, van Vianen, W, Klaassen, CHW, Vos, MC, Severin, JA (B27) 2020; 41 Haller, S, Kramer, R, Becker, K, Bohnert, JA, Eckmanns, T, Hans, JB, Hecht, J, Heidecke, CD, Hubner, NO, Kramer, A, Klaper, K, Littmann, M, Marlinghaus, L, Neumann, B, Pfeifer, Y, Pfennigwerth, N, Rogge, S, Schaufler, K, Thurmer, A, Werner, G, Gatermann, S (B24) 2019; 24 Wang, X, Xu, X, Li, Z, Chen, H, Wang, Q, Yang, P, Zhao, C, Ni, M, Wang, H (B52) 2014; 20 Pitout, JD, DeVinney, R (B4) 2017; 6 Zurfluh, K, Nüesch-Inderbinen, M, Morach, M, Zihler Berner, A, Hächler, H, Stephan, R (B79) 2015; 81 Saavedra, SY, Diaz, L, Wiesner, M, Correa, A, Arévalo, SA, Reyes, J, Hidalgo, AM, de la Cadena, E, Perenguez, M, Montaño, LA, Ardila, J, Ríos, R, Ovalle, MV, Díaz, P, Porras, P, Villegas, MV, Arias, CA, Beltrán, M, Duarte, C (B37) 2017; 61 Samuelsen, O, Toleman, MA, Hasseltvedt, V, Fuursted, K, Leegaard, TM, Walsh, TR, Sundsfjord, A, Giske, CG (B46) 2011; 17 Zhang, R, Li, J, Wang, Y, Shen, J, Shen, Z, Wang, S (B74) 2019; 74 Papagiannitsis, CC, Kotsakis, SD, Petinaki, E, Vatopoulos, AC, Tzelepi, E, Miriagou, V, Tzouvelekis, LS (B43) 2011; 55 Lazareva, IV, Ageevets, VA, Ershova, TA, Zueva, LP, Goncharov, AE, Darina, MG, Svetlichnaya, YS, Uskov, AN, Sidorenko, SV (B17) 2016; 61 B8 Lascols, C, Peirano, G, Hackel, M, Laupland, KB, Pitout, JD (B44) 2013; 57 Harada, K, Shimizu, T, Mukai, Y, Kuwajima, K, Sato, T, Usui, M, Tamura, Y, Kimura, Y, Miyamoto, T, Tsuyuki, Y, Ohki, A, Kataoka, Y (B19) 2016; 7 Dropa, M, Lincopan, N, Balsalobre, LC, Oliveira, DE, Moura, RA, Fernandes, MR, da Silva, QM, Matté, GR, Sato, MIZ, Matté, MH (B18) 2016; 23 Izdebski, R, Bojarska, K, Baraniak, A, Literacka, E, Herda, M, Zabicka, D, Guzek, A, Polgrabia, M, Hryniewicz, W, Gniadkowski, M (B76) 2015; 20 Baker, S, Thomson, N, Weill, FX, Holt, KE (B2) 2018; 360 Peirano, G, Pillai, DR, Pitondo-Silva, A, Richardson, D, Pitout, JD (B47) 2011; 71 Giddins, MJ, Macesic, N, Annavajhala, MK, Stump, S, Khan, S, McConville, TH, Mehta, M, Gomez-Simmonds, A, Uhlemann, AC (B38) 2017; 62 Khong, WX, Marimuthu, K, Teo, J, Ding, Y, Xia, E, Lee, JJ, Ong, RT, Venkatachalam, I, Cherng, B, Pada, SK, Choong, WL, Smitasin, N, Ooi, ST, Deepak, RN, Kurup, A, Fong, R, Van La, M, Tan, TY, Koh, TH, Lin, RT, Tan, EL, Krishnan, PU, Singh, S, Pitout, JD, Teo, YY, Yang, L, Ng, OT (B84) 2016; 71 Rocha, LKL, dos Santos Neto, RL, da Costa Guimarães, AC, Almeida, ACS, Vilela, MA, de Morais, MMC (B59) 2014; 26 Bocanegra-Ibarias, P, Garza-González, E, Morfín-Otero, R, Barrios, H, Villarreal-Treviño, L, Rodríguez-Noriega, E, Garza-Ramos, U, Petersen-Morfin, S, Silva-Sanchez, J (B35) 2017; 12 Loncaric, I, Cabal Rosel, A, Szostak, MP, Licka, T, Allerberger, F, Ruppitsch, W, Spergser, J (B29) 2020; 10 Giakkoupi, P, Papagiannitsis, CC, Miriagou, V, Pappa, O, Polemis, M, Tryfinopoulou, K, Tzouvelekis, LS, Vatopoulos, AC (B42) 2011; 66 Richter, SN, Frasson, I, Franchin, E, Bergo, C, Lavezzo, E, Barzon, L, Cavallaro, A, Palu, G (B45) 2012; 4 Coelho, A, Mirelis, B, Alonso-Tarrés, C, Nieves Larrosa, M, Miró, E, Clivillé Abad, R, Bartolomé, RM, Castañer, M, Prats, G, Johnson, JR, Navarro, F, González-López, JJ (B41) 2009; 64 Mathers, AJ, Peirano, G, Pitout, JD (B3) 2015; 28 Avgoulea, K, Di Pilato, V, Zarkotou, O, Sennati, S, Politi, L, Cannatelli, A, Themeli-Digalaki, K, Giani, T, Tsakris, A, Rossolini, GM, Pournaras, S (B60) 2018; 62 Tavoschi, L, Forni, S, Porretta, A, Righi, L, Pieralli, F, Menichetti, F, Falcone, M, Gemignani, G, Sani, S, Vivani, P, Bellandi, T, Tacconi, D, Turini, L, Toccafondi, G, Privitera, G, Lopalco, P, Baggiani, A, Gemmi, F, Luchini, G, Petrillo, M, Roti, L, Pezzotti, P, Pantosti, A, Iannazzo, S, Mechi, MT, Rossolini, GM (B68) 2020; 25 Rodrigues, C, Bavlovic, J, Machado, E, Amorim, J, Peixe, L, Novais, A (B70) 2016; 7 Baek, EH, Kim, SE, Kim, S, Lee, S, Cho, OH, In Hong, S, Shin, JH, Hwang, I (B23) 2020; 20 Park, DJ, Yu, JK, Park, KG, Park, YJ (B14) 2015; 21 Turton, JF, Payne, Z, Coward, A, Hopkins, KL, Turton, JA, Doumith, M, Woodford, N (B85) 2018; 67 Zautner, AE, Bunk, B, Pfeifer, Y, Spröer, C, Reichard, U, Eiffert, H, Scheithauer, S, Groß, U, Overmann, J, Bohne, W (B80) 2017; 72 Osterblad, M, Kirveskari, J, Hakanen, AJ, Tissari, P, Vaara, M, Jalava, J (B49) 2012; 67 Lafeuille, E, Decre, D, Mahjoub-Messai, F, Bidet, P, Arlet, G, Bingen, E (B50) 2013; 19 Guo, L, An, J, Ma, Y, Ye, L, Luo, Y, Tao, C, Yang, J (B82) 2016; 11 Manges, AR, Geum, HM, Guo, A, Edens, TJ, Fibke, CD, Pitout, JDD (B6) 2019; 32 Suzuki, Y, Nazareno, PJ, Nakano, R, Mondoy, M, Nakano, A, Bugayong, MP, Bilar, J, Perez, M, Medina, EJ, Saito-Obata, M, Saito, M, Nakashima, K, Oshitani, H, Yano, H (B75) 2019; 86 Bathoorn, E, Tsioutis, C, da Silva Voorham, JM, Scoulica, EV, Ioannidou, E, Zhou, K, Rossen, JW, Gikas, A, Friedrich, AW, Grundmann, H (B81) 2016; 71 Pitout, JD, Nordmann, P, Poirel, L (B88) 2015; 59 Rojas, R, Macesic, N, Tolari, G, Guzman, A, Uhlemann, AC (B31) 2019; 25 Peirano, G, Pitout, JDD (B90) 2019; 79 Ruiz-Garbajosa, P, Hernández-García, M, Beatobe, L, Tato, M, Méndez, MI, Grandal, M, Aranzábal, L, Alonso, S, Lópaz, MÁ, Astray, J, Cantón, R (B16) 2016; 71 Quiñones, D, Valverde, A, Rodríguez-Baños, M, Kobayashi, N, Zayaz, A, Abreu, M, Cantón, R, del Campo, R (B57) 2014; 20 Sonnevend, A, Ghazawi, A, Hashmey, R, Haidermota, A, Girgis, S, Alfaresi, M, Omar, M, Paterson, DL, Zowawi, HM, pal, T (B64) 2017; 61 Wyres, KL, Hawkey, J, Hetland, MAK, Fostervold, A, Wick, RR, Judd, LM, Hamidian, M, Howden, BP, Lohr, IH, Holt, KE (B21) 2019; 74 Rodrigues, C, Machado, E, Ramos, H, Peixe, L, Novais, A (B58) 2014; 304 Gona, F, Barbera, F, Pasquariello, AC, Grossi, P, Gridelli, B, Mezzatesta, ML, Caio, C, Stefani, S, Conaldi, PG (B12) 2014; 20 Novovic, K, Trudic, A, Brkic, S, Vasiljevic, Z, Kojic, M, Medic, D, Cirkovic, I, Jovcic, B (B34) 2017; 61 Shoma, S, Kamruzzaman, M, Ginn, AN, Iredell, JR, Partridge, SR (B53) 2014; 78 Castanheira, M, Farrell, SE, Wanger, A, Rolston, KV, Jones, RN, Mendes, RE (B9) 2013; 19 Naha, S, Sands, K, Mukherjee, S, Roy, C, Rameez, MJ, Saha, B, Dutta, S, Walsh, TR, Basu, S (B66) 2020; 55 Long, SW, Olsen, RJ, Eagar, TN, Beres, SB, Zhao, P, Davis, JJ, Brettin, T, Xia, F, Musser, JM (B32) 2017; 8 Peirano, G, Ahmed-Bentley, J, Fuller, |
| References_xml | – ident: e_1_3_2_71_2 doi: 10.3389/fmicb.2016.01000 – ident: e_1_3_2_85_2 doi: 10.1093/jac/dkw277 – ident: e_1_3_2_36_2 doi: 10.1371/journal.pone.0179651 – volume: 61 start-page: 28 year: 2016 ident: e_1_3_2_18_2 article-title: Prevalence and antibiotic resistance of carbapenemase-producing Gram-negative bacteria in Saint Petersburg and some other regions of the Russian federation publication-title: Antibiot Khimioter – ident: e_1_3_2_51_2 doi: 10.1089/mdr.2012.0219 – ident: e_1_3_2_78_2 doi: 10.1093/jac/dks026 – ident: e_1_3_2_29_2 doi: 10.1016/j.diagmicrobio.2018.02.018 – ident: e_1_3_2_56_2 doi: 10.1128/JCM.01404-14 – ident: e_1_3_2_50_2 doi: 10.1093/jac/dks299 – ident: e_1_3_2_43_2 doi: 10.1093/jac/dkr166 – ident: e_1_3_2_68_2 doi: 10.1016/j.ijantimicag.2018.04.004 – ident: e_1_3_2_16_2 doi: 10.1016/j.diagmicrobio.2015.07.023 – ident: e_1_3_2_66_2 doi: 10.1089/mdr.2017.0165 – ident: e_1_3_2_48_2 doi: 10.1016/j.diagmicrobio.2011.06.013 – ident: e_1_3_2_86_2 doi: 10.1099/jmm.0.000653 – ident: e_1_3_2_38_2 doi: 10.1128/AAC.00841-17 – ident: e_1_3_2_80_2 doi: 10.1128/AEM.00258-15 – ident: e_1_3_2_58_2 doi: 10.1089/mdr.2013.0021 – ident: e_1_3_2_32_2 doi: 10.3201/eid2508.171730 – ident: e_1_3_2_19_2 doi: 10.1007/s11356-016-6079-5 – ident: e_1_3_2_27_2 doi: 10.1093/jac/dkz550 – ident: e_1_3_2_4_2 doi: 10.1128/CMR.00116-14 – ident: e_1_3_2_82_2 doi: 10.1093/jac/dkv467 – ident: e_1_3_2_54_2 doi: 10.1016/j.diagmicrobio.2013.08.001 – ident: e_1_3_2_87_2 doi: 10.1007/s10096-013-2022-6 – ident: e_1_3_2_75_2 doi: 10.1093/jac/dkz193 – ident: e_1_3_2_34_2 doi: 10.1016/j.jgar.2019.06.005 – ident: e_1_3_2_41_2 doi: 10.1093/jac/dkn287 – ident: e_1_3_2_49_2 doi: 10.1128/AAC.06142-11 – ident: e_1_3_2_23_2 doi: 10.3201/eid2504.181482 – ident: e_1_3_2_61_2 doi: 10.1128/AAC.02457-17 – ident: e_1_3_2_81_2 doi: 10.1093/jac/dkx216 – ident: e_1_3_2_40_2 doi: 10.1093/cid/cix270 – ident: e_1_3_2_5_2 doi: 10.12688/f1000research.10609.1 – ident: e_1_3_2_52_2 doi: 10.1128/JCM.00162-14 – ident: e_1_3_2_60_2 doi: 10.1016/j.ijid.2014.04.026 – ident: e_1_3_2_10_2 doi: 10.1089/mdr.2012.0238 – ident: e_1_3_2_22_2 doi: 10.1093/jac/dky492 – ident: e_1_3_2_35_2 doi: 10.1128/AAC.02550-16 – ident: e_1_3_2_24_2 doi: 10.1186/s12879-020-4889-z – ident: e_1_3_2_70_2 doi: 10.2807/1560-7917.ES.2017.22.49.17-00048 – ident: e_1_3_2_2_2 doi: 10.1016/j.meegid.2020.104265 – ident: e_1_3_2_53_2 doi: 10.1089/mdr.2013.0100 – ident: e_1_3_2_37_2 doi: 10.1089/mdr.2018.0327 – ident: e_1_3_2_7_2 doi: 10.1128/CMR.00135-18 – ident: e_1_3_2_8_2 doi: 10.1128/CMR.00102-19 – ident: e_1_3_2_11_2 doi: 10.1016/j.ijantimicag.2013.02.017 – ident: e_1_3_2_72_2 doi: 10.3389/fmicb.2016.01859 – ident: e_1_3_2_74_2 doi: 10.3389/fvets.2018.00062 – ident: e_1_3_2_62_2 – ident: e_1_3_2_9_2 – ident: e_1_3_2_45_2 doi: 10.1128/AAC.01686-12 – ident: e_1_3_2_77_2 doi: 10.2807/1560-7917.es2015.20.23.21150 – ident: e_1_3_2_21_2 doi: 10.1099/mgen.0.000110 – ident: e_1_3_2_76_2 doi: 10.1128/AEM.01906-19 – ident: e_1_3_2_84_2 doi: 10.1016/j.jhin.2018.10.022 – ident: e_1_3_2_3_2 doi: 10.1126/science.aar3777 – ident: e_1_3_2_17_2 doi: 10.1093/jac/dkv355 – ident: e_1_3_2_39_2 doi: 10.1128/AAC.02101-17 – ident: e_1_3_2_44_2 doi: 10.1128/AAC.00238-11 – ident: e_1_3_2_6_2 doi: 10.1038/s41579-019-0315-1 – ident: e_1_3_2_79_2 doi: 10.1016/j.diagmicrobio.2013.11.024 – ident: e_1_3_2_89_2 doi: 10.1128/AAC.01019-15 – ident: e_1_3_2_67_2 doi: 10.1016/j.ijantimicag.2020.105903 – ident: e_1_3_2_31_2 doi: 10.3389/fmicb.2018.00150 – ident: e_1_3_2_88_2 doi: 10.1016/j.jgar.2017.10.023 – ident: e_1_3_2_47_2 doi: 10.1111/j.1469-0691.2011.03532.x – ident: e_1_3_2_15_2 doi: 10.1089/mdr.2015.0001 – ident: e_1_3_2_28_2 doi: 10.1017/ice.2019.304 – ident: e_1_3_2_13_2 doi: 10.1111/1469-0691.12577 – ident: e_1_3_2_30_2 doi: 10.3390/ani10020332 – ident: e_1_3_2_63_2 doi: 10.1128/AAC.02610-16 – ident: e_1_3_2_73_2 doi: 10.1128/AAC.02640-16 – ident: e_1_3_2_69_2 doi: 10.2807/1560-7917.ES.2020.25.6.2000085 – ident: e_1_3_2_90_2 doi: 10.3389/fmicb.2020.00271 – ident: e_1_3_2_83_2 doi: 10.1371/journal.pone.0160754 – ident: e_1_3_2_46_2 doi: 10.1186/1757-4749-4-7 – ident: e_1_3_2_64_2 doi: 10.1128/AAC.00454-17 – ident: e_1_3_2_42_2 doi: 10.1093/jac/dkp264 – ident: e_1_3_2_26_2 doi: 10.1099/mgen.0.000349 – ident: e_1_3_2_55_2 doi: 10.1099/jmm.0.073767-0 – ident: e_1_3_2_20_2 doi: 10.3389/fmicb.2016.01021 – ident: e_1_3_2_14_2 doi: 10.1128/AAC.01775-15 – ident: e_1_3_2_59_2 doi: 10.1016/j.ijmm.2014.08.003 – ident: e_1_3_2_65_2 doi: 10.1128/AAC.00418-17 – ident: e_1_3_2_12_2 doi: 10.1371/journal.pone.0132936 – ident: e_1_3_2_33_2 doi: 10.1128/mBio.00489-17 – ident: e_1_3_2_57_2 doi: 10.1111/1469-0691.12727 – ident: e_1_3_2_25_2 doi: 10.2807/1560-7917.ES.2019.24.50.1900734 – ident: e_1_3_2_91_2 doi: 10.1007/s40265-019-01180-3 – volume: 65 start-page: 208 year: 2017 end-page: 215 ident: B39 article-title: Gastrointestinal carriage is a major reservoir of Klebsiella pneumoniae infection in intensive care patients publication-title: Clin Infect Dis doi: 10.1093/cid/cix270 – volume: 86 year: 2019 ident: B75 article-title: Environmental presence and genetic characteristics of carbapenemase-producing Enterobacteriaceae from hospital sewage and river water in the Philippines publication-title: Appl Environ Microbiol doi: 10.1128/AEM.01906-19 – volume: 81 start-page: 104265 year: 2020 ident: B1 article-title: The evolutionary puzzle of Escherichia coli ST131 publication-title: Infect Genet Evol doi: 10.1016/j.meegid.2020.104265 – volume: 18 start-page: 344 year: 2020 end-page: 359 ident: B5 article-title: Population genomics of Klebsiella pneumoniae publication-title: Nat Rev Microbiol doi: 10.1038/s41579-019-0315-1 – volume: 18 start-page: 238 year: 2019 end-page: 242 ident: B33 article-title: Changing epidemiology of KPC-producing Klebsiella pneumoniae in Argentina: emergence of hypermucoviscous ST25 and high-risk clone ST307 publication-title: J Glob Antimicrob Resist doi: 10.1016/j.jgar.2019.06.005 – volume: 74 start-page: 577 year: 2019 end-page: 581 ident: B21 article-title: Emergence and rapid global dissemination of CTX-M-15-associated Klebsiella pneumoniae strain ST307 publication-title: J Antimicrob Chemother doi: 10.1093/jac/dky492 – volume: 60 start-page: 332 year: 2016 end-page: 342 ident: B13 article-title: A two-year surveillance in five Colombian tertiary care hospitals reveals high frequency of non-CG258 clones of carbapenem-resistant Klebsiella pneumoniae with distinct clinical characteristics publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01775-15 – volume: 64 start-page: 862 year: 2009 end-page: 864 ident: B41 article-title: Detection of three stable genetic clones of CTX-M-15-producing Klebsiella pneumoniae in the Barcelona metropolitan area, Spain publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkp264 – volume: 33 start-page: 837 year: 2014 end-page: 843 ident: B86 article-title: Fitness cost associated with resistance to fluoroquinolones is diverse across clones of Klebsiella pneumoniae and may select for CTX-M-15 type extended-spectrum beta-lactamase publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-013-2022-6 – volume: 360 start-page: 733 year: 2018 end-page: 738 ident: B2 article-title: Genomic insights into the emergence and spread of antimicrobial-resistant bacterial pathogens publication-title: Science doi: 10.1126/science.aar3777 – volume: 11 start-page: 271 year: 2020 ident: B89 article-title: Global evolution of pathogenic bacteria with extensive use of fluoroquinolone agents publication-title: Front Microbiol doi: 10.3389/fmicb.2020.00271 – volume: 26 start-page: 49 year: 2014 end-page: 50 ident: B59 article-title: Plasmid-mediated qnrA1 in Klebsiella pneumoniae ST147 in Recife, Brazil publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2014.04.026 – volume: 101 start-page: 142 year: 2019 end-page: 149 ident: B83 article-title: Successful control of the first OXA-48 and/or NDM carbapenemase-producing Klebsiella pneumoniae outbreak in Slovenia 2014–2016 publication-title: J Hosp Infect doi: 10.1016/j.jhin.2018.10.022 – volume: 7 start-page: 1021 year: 2016 ident: B19 article-title: Phenotypic and molecular characterization of antimicrobial resistance in Klebsiella spp. isolates from companion animals in Japan: clonal dissemination of multidrug-resistant extended-spectrum beta-lactamase-producing Klebsiella pneumoniae publication-title: Front Microbiol doi: 10.3389/fmicb.2016.01021 – volume: 20 start-page: 144 year: 2014 end-page: 149 ident: B52 article-title: An outbreak of a nosocomial NDM-1-producing Klebsiella pneumoniae ST147 at a teaching hospital in mainland China publication-title: Microb Drug Resist doi: 10.1089/mdr.2013.0100 – volume: 7 start-page: 1859 year: 2016 ident: B71 article-title: High prevalence of gut microbiota colonization with broad-spectrum cephalosporin resistant Enterobacteriaceae in a Tunisian Intensive care unit publication-title: Front Microbiol doi: 10.3389/fmicb.2016.01859 – volume: 25 start-page: 739 year: 2019 end-page: 747 ident: B22 article-title: Klebsiella pneumoniae ST307 with blaOXA-181, South Africa, 2014–2016 publication-title: Emerg Infect Dis doi: 10.3201/eid2504.181482 – volume: 74 start-page: 2209 year: 2019 end-page: 2213 ident: B74 article-title: Presence of NDM in non-E. coli Enterobacteriaceae in the poultry production environment publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkz193 – volume: 62 year: 2017 ident: B38 article-title: Successive emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in blaKPC-2-harboring Klebsiella pneumoniae sequence type 307 isolates publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02101-17 – volume: 19 start-page: 295 year: 2013 end-page: 297 ident: B9 article-title: Rapid expansion of KPC-2-producing Klebsiella pneumoniae isolates in two Texas hospitals due to clonal spread of ST258 and ST307 lineages publication-title: Microb Drug Resist doi: 10.1089/mdr.2012.0238 – volume: 71 start-page: 106 year: 2011 end-page: 109 ident: B47 article-title: The characteristics of NDM-producing Klebsiella pneumoniae from Canada publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2011.06.013 – volume: 5 start-page: 62 year: 2018 ident: B73 article-title: High prevalence of extended-spectrum beta-lactamase producing Enterobacteriaceae among clinical isolates from cats and dogs admitted to a veterinary hospital in Switzerland publication-title: Front Vet Sci doi: 10.3389/fvets.2018.00062 – volume: 56 start-page: 2735 year: 2012 end-page: 2738 ident: B48 article-title: Diverse sequence types of Klebsiella pneumoniae contribute to the dissemination of blaNDM-1 in India, Sweden, and the United Kingdom publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.06142-11 – volume: 304 start-page: 1100 year: 2014 end-page: 1108 ident: B58 article-title: Expansion of ESBL-producing Klebsiella pneumoniae in hospitalized patients: a successful story of international clones (ST15, ST147, ST336) and epidemic plasmids (IncR, IncFIIK) publication-title: Int J Med Microbiol doi: 10.1016/j.ijmm.2014.08.003 – volume: 10 year: 2015 ident: B11 article-title: An update of the evolving epidemic of blaKPC carrying Klebsiella pneumoniae in Sicily, Italy, 2014: emergence of multiple non-ST258 clones publication-title: PLoS One doi: 10.1371/journal.pone.0132936 – volume: 62 start-page: 978 year: 2008 end-page: 985 ident: B40 article-title: Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005—the new ‘MRSAs’? publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkn287 – volume: 20 start-page: 45 year: 2014 end-page: 51 ident: B57 article-title: High clonal diversity in a non-outbreak situation of clinical ESBL-producing Klebsiella pneumoniae isolates in the first national surveillance program in Cuba publication-title: Microb Drug Resist doi: 10.1089/mdr.2013.0021 – volume: 25 start-page: 787 year: 2019 end-page: 790 ident: B36 article-title: Identification of blaVIM-1 gene in ST307 and ST661 Klebsiella pneumoniae clones in Italy: old acquaintances for new combinations publication-title: Microb Drug Resist doi: 10.1089/mdr.2018.0327 – volume: 62 year: 2018 ident: B60 article-title: Characterization of extensively drug-resistant or pandrug-resistant sequence type 147 and 101 OXA-48-producing Klebsiella pneumoniae causing bloodstream infections in patients in an intensive care unit publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02457-17 – volume: 32 year: 2019 ident: B6 article-title: Global extraintestinal pathogenic Escherichia coli (ExPEC) Lineages publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00135-18 – volume: 41 start-page: 524 year: 2013 end-page: 526 ident: B10 article-title: High prevalence of 16S rRNA methylase RmtB among CTX-M extended-spectrum beta-lactamase-producing Klebsiella pneumoniae from Islamabad, Pakistan publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2013.02.017 – volume: 61 year: 2017 ident: B64 article-title: Multihospital occurrence of pan-resistant klebsiella pneumoniae Sequence Type 147 with an ISEcp1-directed blaOXA-181 insertion in the mgrB gene in the United Arab Emirates publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00418-17 – volume: 55 start-page: 105903 year: 2020 ident: B66 article-title: KPC-2-producing Klebsiella pneumoniae ST147 in a neonatal unit: clonal isolates with differences in colistin susceptibility attributed to AcrAB-TolC pump publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2020.105903 – volume: 20 start-page: 21150 year: 2015 ident: B76 article-title: NDM-1- or OXA-48-producing Enterobacteriaceae colonising Polish tourists following a terrorist attack in Tunis, March 2015 publication-title: Euro Surveill doi: 10.2807/1560-7917.es2015.20.23.21150 – volume: 6 start-page: 195 year: 2017 ident: B4 article-title: Escherichia coli ST131: a multidrug-resistant clone primed for global domination publication-title: F1000Res doi: 10.12688/f1000research.10609.1 – ident: B8 article-title: World Health Organization . 2017 . Global priority list of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics. https://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/ . – volume: 20 start-page: O633 year: 2014 end-page: O635 ident: B12 article-title: In vivo multiclonal transfer of bla(KPC-3) from Klebsiella pneumoniae to Escherichia coli in surgery patients publication-title: Clin Microbiol Infect doi: 10.1111/1469-0691.12577 – volume: 23 start-page: 4953 year: 2016 end-page: 4958 ident: B18 article-title: Genetic background of novel sequence types of CTX-M-8- and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae from public wastewater treatment plants in Sao Paulo, Brazil publication-title: Environ Sci Pollut Res Int doi: 10.1007/s11356-016-6079-5 – volume: 61 year: 2017 ident: B63 article-title: NDM-5 and OXA-181 beta-lactamases, a significant threat continues to spread in the Americas publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00454-17 – year: 2020 ident: B25 article-title: Whole-genome sequencing resolves a polyclonal outbreak by extended-spectrum beta-lactam and carbapenem-resistant Klebsiella pneumoniae in a Portuguese tertiary-care hospital publication-title: Microb Genom doi: 10.1099/mgen.0.000349 – volume: 71 start-page: 3081 year: 2016 end-page: 3089 ident: B84 article-title: Tracking inter-institutional spread of NDM and identification of a novel NDM-positive plasmid, pSg1-NDM, using next-generation sequencing approaches publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkw277 – volume: 61 year: 2017 ident: B72 article-title: Highly tigecycline-resistant Klebsiella pneumoniae Sequence type 11 (ST11) and ST147 isolates from companion animals publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02640-16 – volume: 78 start-page: 277 year: 2014 end-page: 281 ident: B78 article-title: Molecular epidemiology of Enterobacteriaceae that produce VIMs and IMPs from the SMART surveillance program publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2013.11.024 – volume: 71 start-page: 348 year: 2016 end-page: 352 ident: B16 article-title: A single-day point-prevalence study of faecal carriers in long-term care hospitals in Madrid (Spain) depicts a complex clonal and polyclonal dissemination of carbapenemase-producing Enterobacteriaceae publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkv355 – volume: 20 start-page: O1121 year: 2014 end-page: O1123 ident: B56 article-title: Molecular epidemiology of OXA-48-producing Klebsiella pneumoniae in France publication-title: Clin Microbiol Infect doi: 10.1111/1469-0691.12727 – volume: 61 year: 2017 ident: B37 article-title: Genomic and molecular characterization of clinical isolates of Enterobacteriaceae harboring mcr-1 in Colombia, 2002 to 2016 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00841-17 – volume: 17 start-page: 1811 year: 2011 end-page: 1816 ident: B46 article-title: Molecular characterization of VIM-producing Klebsiella pneumoniae from Scandinavia reveals genetic relatedness with international clonal complexes encoding transferable multidrug resistance publication-title: Clin Microbiol Infect doi: 10.1111/j.1469-0691.2011.03532.x – volume: 21 start-page: 622 year: 2015 end-page: 630 ident: B14 article-title: Genotypes of ciprofloxacin-resistant Klebsiella pneumoniae in Korea and their characteristics according to the genetic lineages publication-title: Microb Drug Resist doi: 10.1089/mdr.2015.0001 – volume: 91 start-page: 275 year: 2018 end-page: 281 ident: B28 article-title: Multidrug-resistant infections in long-term care facilities: extended-spectrum beta-lactamase-producing Enterobacteriaceae and hypervirulent antibiotic resistant Clostridium difficile publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2018.02.018 – volume: 61 year: 2017 ident: B34 article-title: Molecular epidemiology of colistin-resistant, carbapenemase-producing Klebsiella pneumoniae in Serbia from 2013 to 2016 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02550-16 – volume: 67 start-page: 118 year: 2018 end-page: 128 ident: B85 article-title: Virulence genes in isolates of Klebsiella pneumoniae from the UK during 2016, including among carbapenemase gene-positive hypervirulent K1-ST23 and 'non-hypervirulent' types ST147, ST15 and ST383 publication-title: J Med Microbiol doi: 10.1099/jmm.0.000653 – volume: 78 start-page: 93 year: 2014 end-page: 97 ident: B53 article-title: Characterization of multidrug-resistant Klebsiella pneumoniae from Australia carrying blaNDM-1 publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2013.08.001 – volume: 22 start-page: 17-00048 year: 2017 ident: B69 article-title: Analysis of OXA-204 carbapenemase-producing Enterobacteriaceae reveals possible endoscopy-associated transmission, France, 2012 to 2014 publication-title: Euro Surveill doi: 10.2807/1560-7917.ES.2017.22.49.17-00048 – volume: 25 start-page: 2000085 year: 2020 ident: B68 article-title: Prolonged outbreak of New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE), Tuscany, Italy, 2018 to 2019 publication-title: Euro Surveill doi: 10.2807/1560-7917.ES.2020.25.6.2000085 – volume: 81 start-page: 3115 year: 2015 end-page: 3120 ident: B79 article-title: Extended-spectrum-beta-lactamase-producing Enterobacteriaceae isolated from vegetables imported from the Dominican Republic, India, Thailand, and Vietnam publication-title: Appl Environ Microbiol doi: 10.1128/AEM.00258-15 – volume: 72 start-page: 2737 year: 2017 end-page: 2744 ident: B80 article-title: Monitoring microevolution of OXA-48-producing Klebsiella pneumoniae ST147 in a hospital setting by SMRT sequencing publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkx216 – volume: 79 start-page: 1529 year: 2019 end-page: 1541 ident: B90 article-title: Extended-spectrum beta-lactamase-producing Enterobacteriaceae: update on molecular epidemiology and treatment options publication-title: Drugs doi: 10.1007/s40265-019-01180-3 – volume: 67 start-page: 1114 year: 2012 end-page: 1120 ident: B77 article-title: Molecular epidemiology of extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae over a 10 year period in Calgary, Canada publication-title: J Antimicrob Chemother doi: 10.1093/jac/dks026 – volume: 28 start-page: 565 year: 2015 end-page: 591 ident: B3 article-title: The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00116-14 – volume: 12 year: 2017 ident: B35 article-title: Molecular and microbiological report of a hospital outbreak of NDM-1-carrying Enterobacteriaceae in Mexico publication-title: PLoS One doi: 10.1371/journal.pone.0179651 – volume: 3 year: 2017 ident: B20 article-title: Diversity, virulence, and antimicrobial resistance of the KPC-producing Klebsiella pneumoniae ST307 clone publication-title: Microb Genom doi: 10.1099/mgen.0.000110 – volume: 52 start-page: 331 year: 2018 end-page: 337 ident: B67 article-title: Hospital outbreak due to a Klebsiella pneumoniae ST147 clonal strain co-producing KPC-2 and VIM-1 carbapenemases in a tertiary teaching hospital in northern Greece publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2018.04.004 – volume: 11 year: 2016 ident: B82 article-title: Nosocomial outbreak of OXA-48-producing Klebsiella pneumoniae in a Chinese hospital: clonal transmission of ST147 and ST383 publication-title: PLoS One doi: 10.1371/journal.pone.0160754 – volume: 83 start-page: 298 year: 2015 end-page: 304 ident: B15 article-title: Dissemination of multidrug-resistant blaCTX-M-15/IncFIIk plasmids in Klebsiella pneumoniae isolates from hospital- and community-acquired human infections in Tunisia publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2015.07.023 – volume: 55 start-page: 3570 year: 2011 end-page: 3572 ident: B43 article-title: Characterization of metallo-beta-lactamase VIM-27, an A57S mutant of VIM-1 associated with Klebsiella pneumoniae ST147 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00238-11 – volume: 52 start-page: 1575 year: 2014 end-page: 1581 ident: B51 article-title: Travel-related carbapenemase-producing Gram-negative bacteria in Alberta, Canada: the first 3 years publication-title: J Clin Microbiol doi: 10.1128/JCM.00162-14 – volume: 24 start-page: 1137 year: 2018 end-page: 1147 ident: B65 article-title: An outbreak of NDM-1-producing Klebsiella pneumoniae, associated with OmpK35 and OmpK36 porin loss in Tunisia publication-title: Microb Drug Resist doi: 10.1089/mdr.2017.0165 – volume: 66 start-page: 1510 year: 2011 end-page: 1513 ident: B42 article-title: An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10) publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkr166 – volume: 41 start-page: 31 year: 2020 end-page: 36 ident: B27 article-title: An outbreak of ST307 extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae in a rehabilitation center: An unusual source and route of transmission publication-title: Infect Control Hosp Epidemiol doi: 10.1017/ice.2019.304 – volume: 33 year: 2019 ident: B7 article-title: The global ascendency of OXA-48-type carbapenemases publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00102-19 – volume: 24 start-page: 1900734 year: 2019 ident: B24 article-title: Extensively drug-resistant Klebsiella pneumoniae ST307 outbreak, north-eastern Germany, June to October 2019 publication-title: Euro Surveill doi: 10.2807/1560-7917.ES.2019.24.50.1900734 – volume: 67 start-page: 2860 year: 2012 end-page: 2864 ident: B49 article-title: Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008-11) publication-title: J Antimicrob Chemother doi: 10.1093/jac/dks299 – volume: 4 start-page: 7 year: 2012 ident: B45 article-title: KPC-mediated resistance in Klebsiella pneumoniae in two hospitals in Padua, Italy, June 2009-December 2011: massive spreading of a KPC-3-encoding plasmid and involvement of non-intensive care units publication-title: Gut Pathog doi: 10.1186/1757-4749-4-7 – volume: 61 year: 2017 ident: B62 article-title: Importance of clonal complex 258 and IncFK2-like plasmids among a global collection of Klebsiella pneumoniae with blaKPC publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.02610-16 – volume: 59 start-page: 5873 year: 2015 end-page: 5884 ident: B88 article-title: Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01019-15 – volume: 9 start-page: 150 year: 2018 ident: B30 article-title: Clinically relevant ESBL-producing K. pneumoniae ST307 and E. coli ST38 in an urban West African rat population publication-title: Front Microbiol doi: 10.3389/fmicb.2018.00150 – volume: 13 start-page: 98 year: 2018 end-page: 103 ident: B87 article-title: Spread of Klebsiella pneumoniae ST395 non-susceptible to carbapenems and resistant to fluoroquinolones in north-eastern France publication-title: J Glob Antimicrob Resist doi: 10.1016/j.jgar.2017.10.023 – volume: 20 start-page: 166 year: 2020 ident: B23 article-title: Successful control of an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae ST307 outbreak in a neonatal intensive care unit publication-title: BMC Infect Dis doi: 10.1186/s12879-020-4889-z – volume: 8 year: 2017 ident: B32 article-title: Population genomic analysis of 1,777 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates, Houston, Texas: unexpected abundance of clonal group 307 publication-title: mBio doi: 10.1128/mBio.00489-17 – volume: 75 start-page: 896 year: 2020 end-page: 902 ident: B26 article-title: Klebsiella pneumoniae ST307 with OXA-181: threat of a high-risk clone and promiscuous plasmid in a resource-constrained healthcare setting publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkz550 – volume: 7 start-page: 1000 year: 2016 ident: B70 article-title: KPC-3-producing Klebsiella pneumoniae in Portugal linked to previously circulating non-CG258 lineages and uncommon genetic platforms (Tn4401d-IncFIA and Tn4401d-IncN) publication-title: Front Microbiol doi: 10.3389/fmicb.2016.01000 – volume: 57 start-page: 130 year: 2013 end-page: 136 ident: B44 article-title: Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01686-12 – volume: 19 start-page: 491 year: 2013 end-page: 497 ident: B50 article-title: OXA-48 carbapenemase-producing Klebsiella pneumoniae isolated from Libyan patients publication-title: Microb Drug Resist doi: 10.1089/mdr.2012.0219 – volume: 63 start-page: 1316 year: 2014 end-page: 1323 ident: B54 article-title: Enterobacteriaceae isolates carrying the New Delhi metallo-beta-lactamase gene in Yemen publication-title: J Med Microbiol doi: 10.1099/jmm.0.073767-0 – volume: 10 start-page: 332 year: 2020 ident: B29 article-title: Broad-spectrum cephalosporin-resistant Klebsiella spp. isolated from diseased horses in Austria publication-title: Animals doi: 10.3390/ani10020332 – volume: 25 start-page: 1583 year: 2019 end-page: 1585 ident: B31 article-title: Multidrug-resistant Klebsiella pneumoniae ST307 in traveler returning from Puerto Rico to Dominican Republic publication-title: Emerg Infect Dis doi: 10.3201/eid2508.171730 – volume: 52 start-page: 4109 year: 2014 end-page: 4110 ident: B55 article-title: Klebsiella pneumoniae ST147 coproducing NDM-7 carbapenemase and RmtF 16S rRNA methyltransferase in Minnesota publication-title: J Clin Microbiol doi: 10.1128/JCM.01404-14 – volume: 71 start-page: 1207 year: 2016 end-page: 1212 ident: B81 article-title: Emergence of pan-resistance in KPC-2 carbapenemase-producing Klebsiella pneumoniae in Crete, Greece: a close call publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkv467 – volume: 61 start-page: 28 year: 2016 end-page: 38 ident: B17 article-title: Prevalence and antibiotic resistance of carbapenemase-producing Gram-negative bacteria in Saint Petersburg and some other regions of the Russian federation publication-title: Antibiot Khimioter – ident: B61 article-title: Chen LPG , Bradford P , Motyl M , Kreiswirth B , Pitout JD . 2017 . Genomic diversity and global epidemiology of carbapenem-resistant K. pneumoniae (CRKp) clonal group 147 (CG147), abstr 25. ASM Microbe, New Orleans, LA, USA. |
| SSID | ssj0006590 |
| Score | 2.6735198 |
| SecondaryResourceType | review_article |
| Snippet | There is an enormous global public health burden due to antimicrobial-resistant (AMR)
Klebsiella pneumoniae
high-risk clones.
K. pneumoniae
ST307 and ST147 are... There is an enormous global public health burden due to antimicrobial-resistant (AMR) high-risk clones. ST307 and ST147 are recent additions to the family of... There is an enormous global public health burden due to antimicrobial-resistant (AMR) Klebsiella pneumoniae high-risk clones. K. pneumoniae ST307 and ST147 are... |
| SourceID | pubmedcentral proquest asm2 pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| SubjectTerms | Minireview |
| Title | Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147 |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/32747358 https://journals.asm.org/doi/10.1128/AAC.01148-20 https://www.proquest.com/docview/2430370730 https://pubmed.ncbi.nlm.nih.gov/PMC7508593 |
| Volume | 64 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKEIgXBAVG-ZJBsJcsxflOHkv5qIBN09SJvUV26myR2jA16UMRfzx3dr46WmkgVVGVOo7V-_l8Z9_9jpC30mUSVb9pi0SYyFdihoAT00pl4LqRiESCyclHx_7kzP167p33er-72SWlGCa_tuaV_I9U4R7IFbNk_0GyTadwA76DfOEKEobrjWSMO0qqyNAoL7NFpjiV-Nw8lQVahXmpojjMU4we_zaXosgw1Mm4yuUKhphxaYznSNUPZiHMQR3EObU0NWXDTNvt2eAXKiFO5cJdykWVvbVu9WsGS5_afP2iyji1wQNau30HMF40On4pM6wepXd2PvDlcm0cD5u-QNWsyipamOe58XEIn-4mBXikeG5jdRWv75tuqCsND6XWtUhl6nu6oG2tjDWleQ06tl3J25i4MBqNh8qbM23WLmb1Af61Na6JPFQ-jx3G8HSsno5tdovctoNAHfJPJq3zBEPTCUzV0Ou0CTt83303rOW8WNibds1fzsr1mNuOETN9QO5X3gcdaSg9JD2Z98kdXY903Sd3j6pIiz45ONGc5utDOm1T9IpDekBPWrbz9SPyowYh3QFC2oCQtiCkLQipBiFVIKQALapA-Jicff40HU_MqlqHyV0rLE3QBmA8MieaOS6zZyxljkgjkVrCdwLLSyNuMcEjyQTjYBB5XmKlYehzaWFNBStxnpC9HN73lNA0QX6GmSc86bsB-LAySmceHmA7GDbgDcgb_MvjaioW8TapDohRCyROKr57LLsy39H6XdP6SvO87Gj3upZtDIoYT9d4Ln-uith2wRoMcMUckH0t66YnB_d-HC8ckGADBU0DJHnf_CXPLhXZO1j0SEn47Ibje07utfPvBdkrlyv5EszmUrxS6P4DtTK8LA |
| linkProvider | ABC ChemistRy |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Emerging+Antimicrobial-Resistant+High-Risk+Klebsiella+pneumoniae+Clones+ST307+and+ST147&rft.jtitle=Antimicrobial+agents+and+chemotherapy&rft.au=Peirano%2C+Gisele&rft.au=Chen%2C+Liang&rft.au=Kreiswirth%2C+Barry+N.&rft.au=Pitout%2C+Johann+D.+D.&rft.date=2020-09-21&rft.issn=0066-4804&rft.eissn=1098-6596&rft.volume=64&rft.issue=10&rft_id=info:doi/10.1128%2FAAC.01148-20&rft.externalDBID=n%2Fa&rft.externalDocID=10_1128_AAC_01148_20 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0066-4804&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0066-4804&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0066-4804&client=summon |